The Translational Cancer and Immunity Center
Back to Research PageInterdisciplinary Research Program (IDRP) - Identifying Novel Diagnostic and Predictive Biomarkers for Breast Cancer in Qatar
Aim
To explore two main areas within breast cancer research. The first area is the identification of genetic determinants of non-BRCA1/2-linked familial breast cancer, with the second area being the search for novel biomarkers for diagnosis, prognosis, and prediction of therapy response of breast cancer. The ultimate goal of the program is to identify novel biomarkers for breast cancer that contribute to the improvement of patient survival in Qatar and the MENA region.
Scientific Coordinators
Investigators
-
Dr. Julie Decock
Translational Cancer and Immunity Center (TCIC) -
Dr. Fares Al-Ejeh
Translational Cancer and Immunity Center (TCIC) -
Dr. Mariam Al-Muftah
Translational Cancer and Immunity Center (TCIC) -
Dr. Khalid Ouararhni
Translational Cancer and Immunity Center (TCIC) -
Dr. Paul Thornalley
Diabetes Research Center (DRC) -
Dr. Abdelilah Arredouani
Diabetes Research Center (DRC) -
Dr. Omar El-Agnaf
Neurological Disorders Research Center (NDRC) -
Dr. Hyung Kim
Neurological Disorders Research Center (NDRC) -
Dr. Houari Abdesselem
Neurological Disorders Research Center (NDRC)
Collaborators
- Dr. Salahddin Gehani
Hamad Medical Corporation (HMC) - Dr. Salha Bujassoum
Hamad Medical Corporation (HMC) - Hikmat Abdel-Razaq
King Hussein Cancer Center (KHCC), Jordan - Dr. Omar Albagha
College of Health and Life Sciences (CHLS), HBKU
Interdisciplinary Research Program (IDRP)- Integrative, Translational Research Against COVID-19
Aim
This program aims to (1) develop diagnostic and predictive biomarkers for infection, COVID-19 complications and immunity, (2) identify the therapeutic potential for preventing infection and treating COVID-19 using in-house tools and models, and (3) build capacity for research, development and innovation and foster preparedness in Qatar against coronaviruses.
Scientific Coordinators
Investigators
-
Dr. Nehad Alajez
Translational Cancer and Immunity Center (TCIC) -
Dr. Khalid Ouararhni
Translational Cancer and Immunity Center (TCIC) -
Dr. Paul Thornalley
Diabetes Research Center (DRC) -
Dr. Prasanna Kolatkar
Diabetes Research Center (DRC) -
Dr. Abdelilah Arredouani
Diabetes Research Center (DRC) -
Dr. Heba Al-Siddiqi
Diabetes Research Center (DRC) -
Dr. Omar El-Agnaf
Neurological Disorders Research Center (NDRC) -
Dr. Hyung Kim
Neurological Disorders Research Center (NDRC) -
Dr. Yongsoo Park
Neurological Disorders Research Center (NDRC) -
Dr. Sara Abdulla
Neurological Disorders Research Center (NDRC) -
Dr. Houari Abdesselem
Neurological Disorders Research Center (NDRC)
Collaborators
- Dr. Mariam Al-Nesf (Hamad Medical Corporation)
- Dr. Jassim Al-Suwaidi (Hamad Medical Corporation)
- Dr. Ali Omrani (Hamad Medical Corporation)
- Dr. Nahla Afifi (Qatar Biobank)
- Dr. Vidya Mohamed-Ali (Anti-Doping Lab Qatar)
- Dr. Mohammed Al-Maadheedh (Anti-Doping Lab Qatar)
- Dr. Hadi Yassine (Qatar University)
- Dr. Hebah Al Khatib (Qatar University)
- Dr. Naila Rabbani (Qatar University)
- Resources
- موارد
MYHBKU LOGIN
تسجيل دخول بنر